Deal of the Week: Elsevier/Via Oncology

Deal of the Week: Elsevier/Via Oncology

Deal makers took a break last week, after a long trudge through the J.P. Morgan Healthcare Conference the week before. Deal volume was light in the week of Janaury 17, 2018, but at least 70 transactions have been recorded this month. Here’s an unusual deal from the eHealth sector we picked. Elsevier, a subsidiary of RELX plc (NYSE: RELX), announced its acquisition of Via Oncology, a privately held, former subsidiary of UPMC, based in Pittsburgh. Elsevier is a global provider of information solutions for science, health and technology professionals. Via Oncology provides decision support tools for cancer. Specifically, its Via Pathways product helps cancer centers demonstrate the... Read More »